BALX Holdings, LLC — Form D
BALX Holdings, LLC of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-05-03. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-05-03
- Form: D
- Accession: 0001668511-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Investors: 17
- Date of first sale: 2016-02-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-262496
Issuer
- Name: BALX Holdings, LLC
- CIK: 0001668511
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: C/O RIVERSIDE PARTNERS, LLC, BOSTON, MA, 02116
- Phone: 617-351-2800
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| James A Datin | Director | Cobourg, A6 |
| James A Datin | Executive Officer | Cobourg, A6 |
| David A Belluck | Director | Boston, MA |
| Caroline A Popper | Director | Durham, NC |
| Mike A Magliochetti | Director | Boston, MA |
| Max J Osofsky | Director | Boston, MA |
| Michael J Lehmann | Director | Durham, NC |
| Afshin A Safavi | Director | Durham, NC |
| Afshin A Safavi | Executive Officer | Durham, NC |
| Kurt J Brykman | Director | Durham, MA |
| Todd A Lynch | Executive Officer | Durham, NC |
| Philip J Borden | Director | Boston, MA |
| Jeremy A Goldberg | Director | Durham, NC |
| Craig A Stern | Director | Boston, MA |
Other filings by this issuer (1)
More